J, X., A, G., W, Z., D, Z., & W, L. (2025). Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients. BMC infectious diseases, 25(1), 1443. https://doi.org/10.1186/s12879-025-11857-8
Chicago Style (17th ed.) CitationJ, Xie, Gao A, Zhang W, Zhao D, and Liu W. "Efficacy and Safety of Echinocandins Combined with Trimethoprim-Sulfamethoxazole as First-line Treatment for Pneumocystis Pneumonia in HIV-infected and Non-HIV-infected Patients." BMC Infectious Diseases 25, no. 1 (2025): 1443. https://doi.org/10.1186/s12879-025-11857-8.
MLA (9th ed.) CitationJ, Xie, et al. "Efficacy and Safety of Echinocandins Combined with Trimethoprim-Sulfamethoxazole as First-line Treatment for Pneumocystis Pneumonia in HIV-infected and Non-HIV-infected Patients." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 1443, https://doi.org/10.1186/s12879-025-11857-8.